Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC

NCT00779714 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: DTIC (dacarbazine)
DRUG: paclitaxel + cisplatin
DRUG: treosulfan + cytarabine

Sponsor

University of Wuerzburg

Collaborators

[object Object]
[object Object]
[object Object]